In contrast, recent findings from multiple independent cohorts have shown that plasma p-tau biomarkers (p-tau181, p-tau217, and p-tau231) are strongly associated with both brain Aβ load8–10, the amounts and severity of tau pathology across the AD continuum8, and predict longitudinal changes in brain Aβ pathology11. Here, MAPT is linked to Alzheimer disease.